Figures & data
Figure 2. Characterization of chemical structure of IADA-7. The chemical structure of IADA-7 was analyzed sequentially using an IR spectrum (A), 1H-NMR spectrum (B), and 13C-1H NMR spectrum (C).
![Figure 2. Characterization of chemical structure of IADA-7. The chemical structure of IADA-7 was analyzed sequentially using an IR spectrum (A), 1H-NMR spectrum (B), and 13C-1H NMR spectrum (C).](/cms/asset/a948bc25-b7f2-4384-a4b8-68f5f16736ed/ienz_a_290852_f0002_b.gif)
Figure 4. Cytotoxic effect of IADA-7 on human Jurkat T cells (- - -○- - -) and human bladder carcinoma J 82 cells (•). Both cell lines were treated with the indicated concentration of IADA-7, and its cytotoxic effect was assessed via an MTT assay, as described in the Materials and Methods.
![Figure 4. Cytotoxic effect of IADA-7 on human Jurkat T cells (- - -○- - -) and human bladder carcinoma J 82 cells (•). Both cell lines were treated with the indicated concentration of IADA-7, and its cytotoxic effect was assessed via an MTT assay, as described in the Materials and Methods.](/cms/asset/29ae2a82-7765-44c7-b59c-b60333dadc96/ienz_a_290852_f0004_b.gif)
Figure 5. Effect of purified IADA-7 on Jurkat T cells analysed by flow cytometry. Cells were treated with IADA-7 (15 μg/mL) for 0–48 h and assessed by propidium iodide (PI) staining, as described in Materials and Methods. Grey line represents control cells, and black line represents 24 h, 48 h sample cells, respectively. Apo: apoptotic percentage.
![Figure 5. Effect of purified IADA-7 on Jurkat T cells analysed by flow cytometry. Cells were treated with IADA-7 (15 μg/mL) for 0–48 h and assessed by propidium iodide (PI) staining, as described in Materials and Methods. Grey line represents control cells, and black line represents 24 h, 48 h sample cells, respectively. Apo: apoptotic percentage.](/cms/asset/217f99ee-3392-48d4-9fb3-05a6729d57d7/ienz_a_290852_f0005_b.gif)